colon adenocarcinoma (Cancer)

Search with Google Search with Bing
Information
Disease name
colon adenocarcinoma
Disease ID
DOID:234
Description
"A colon carcinoma that derives_from epithelial cells of glandular origin." [url:http\://en.wikipedia.org/wiki/Adenocarcinoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04068103 Active, not recruiting Phase 2/Phase 3 Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery December 16, 2019 April 30, 2027
NCT03365882 Active, not recruiting Phase 2 S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery November 27, 2017 November 20, 2024
NCT03436563 Active, not recruiting Phase 1/Phase 2 M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability March 7, 2018 August 2023
NCT04963283 Active, not recruiting Phase 2 Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer June 23, 2021 February 9, 2026
NCT02863107 Active, not recruiting Young-Onset Colorectal Cancer June 7, 2012 August 31, 2030
NCT02912559 Active, not recruiting Phase 3 Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair October 16, 2017 April 2, 2025
NCT03949777 Completed N/A Validation of Aer-O-Scope Colonoscope System Cecal Intubation January 6, 2020 November 14, 2021
NCT04003181 Completed N/A The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon September 28, 2017 May 26, 2021
NCT00096278 Completed Phase 3 Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer September 15, 2004 December 31, 2012
NCT02127359 Completed Whole-Exome Sequencing (WES) of Cancer Patients September 2012 December 2019
NCT02368886 Completed Phase 2 Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer March 27, 2015 March 2, 2023
NCT02393755 Completed Phase 1/Phase 2 Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer May 8, 2015 May 18, 2021
NCT02569723 Completed N/A Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy October 16, 2015 April 4, 2020
NCT03871790 Completed Peptide-based Immunization for Colon- and and Pancreas-carcinoma April 1, 2019 August 31, 2022
NCT04349384 Completed Audit of Surgery for Colorectal Cancer January 1, 2018 December 31, 2019
NCT04526314 Completed Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older January 1, 2018 July 1, 2020
NCT05872334 Completed N/A The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery June 1, 2021 April 5, 2023
NCT06216405 Completed N/A Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection January 20, 2022 January 3, 2024
NCT06426927 Not yet recruiting N/A PeLear CCC: Proyecto Latino Contra Cancer Colorectal July 1, 2024 December 30, 2024
NCT04920032 Recruiting Phase 1 Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas August 26, 2021 December 31, 2025
NCT05710406 Recruiting Phase 2/Phase 3 Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer May 30, 2023 August 2034
NCT05186116 Recruiting N/A LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis January 1, 2022 January 1, 2032
NCT05482516 Recruiting Phase 3 Evaluating Novel Therapies in ctDNA Positive GI Cancers March 29, 2023 December 2028
NCT05746195 Recruiting N/A Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) November 3, 2023 November 30, 2024
NCT06414304 Recruiting Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy June 1, 2022 July 2026
NCT06017141 Recruiting Phase 2 Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study May 22, 2023 May 22, 2026
NCT03015038 Unknown status Study of the Immune Response in Colon Adenocarcinoma February 5, 2017 February 2024
NCT04475159 Unknown status Phase 2 Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial August 1, 2020 August 1, 2023
NCT05422547 Unknown status Role of Immunoscore® in Stage II-III Colorectal Cancer April 1, 2022 December 30, 2023
NCT04057274 Unknown status N/A Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth September 23, 2019 September 30, 2020
NCT04863768 Unknown status Molecular Profiling of Colorectal Cancer January 1, 2006 September 2022
NCT02575508 Withdrawn Phase 1/Phase 2 Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer
Disase is a (Disease Ontology)
DOID:1520
Cross Reference ID (Disease Ontology)
MESH:D003110
Cross Reference ID (Disease Ontology)
NCI:C4349
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:255082000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0338106
Exact Synonym (Disease Ontology)
adenocarcinoma of colon
Exact Synonym (Disease Ontology)
Colonic adenocarcinoma
Disase Synonym (Disease Ontology)
adenocarcinoma of the colon